Molecular Vision 2015; 21:124-130 <>
Received 04 November 2014 | Accepted 03 February 2015 | Published 05 February 2015

Ophthalmological phenotype associated with homozygous null mutation in the NEUROD1 gene

Orsolya Orosz,1 Miklós Czeglédi,2 Irén Kántor,3 István Balogh,4 Attila Vajas,1 Lili Takács,1 András Berta,1 Gergely Losonczy1

1Department of Ophthalmology, University of Debrecen, Clinical Center, Debrecen, Hungary; 2Department of Ophthalmology, Jósa András Hospital, Nyíregyháza, Hungary; 3Department of Pediatrics, Jósa András Hospital, Nyíregyháza, Hungary; 4Division of Clinical Genetics, Department of Laboratory Medicine, University of Debrecen, Clinical Center, Debrecen, Hungary

Correspondence to: Gergely Losonczy, Department of Ophthalmology, University of Debrecen, Clinical Center, Debrecen, Hungary; Phone: +3652255456; FAX: +3652255456; email:


Purpose: NEUROD1 is a tissue-specific basic helix loop helix (bHLH) protein involved in the development and maintenance of the endocrine pancreas and neuronal elements. Loss of NEUROD1 causes ataxia, cerebellar hypoplasia, sensorineural deafness, and severe retinal dystrophy in mice. Heterozygous loss-of-function mutations in NEUROD1 have previously been described as a cause of maturity-onset diabetes of the young (MODY) and late-onset diabetes. To date, homozygous loss-of-function NEUROD1 mutations have only been detected in two patients. Both mutations caused permanent neonatal diabetes and severe neurologic defects, including visual impairment. However, a detailed ophthalmological phenotype of this novel syndrome has not yet been reported. Our aim was to characterize the ophthalmological phenotype associated with the previously reported homozygous c.427_428CT mutation in the NEUROD1 gene.

Methods: The female patient was investigated on multiple occasions between 2009 (age 14) and 2014 (age 19), including visual acuity testing, automated perimetry, funduscopy, anterior-segment imaging, optical coherence tomography of the posterior pole, standard full-field electroretinography, and fundus-autofluorescence imaging.

Results: The patient had nyctalopia, blurry vision, and visual field constriction from early childhood. Her best corrected visual acuity ranged between 20/25 and 15/25 during the investigation period. Perimetry showed concentric constriction of the visual field, sparing only the central 30 degrees in both eyes. The anterior segment did not show any morphological changes. Optical coherence tomography revealed total absence of the photoreceptor layer of the retina outside the fovea, where a discoid remnant of cone photoreceptors could be detected. Neither setting of the standard full-field electroretinography could detect any electrical response from the retina. Color fundus photos presented peripheral chorioretinal atrophy and central RPE mottling. A hyperreflective parafoveal ring was detected on fundus autofluorescent photos, a characteristic sign of hereditary retinal dystrophies.

Conclusions: To the best of our knowledge, this is the first report on the ophthalmological phenotype associating with a homozygous NEUROD1 null mutation in humans. Our results indicate that the loss of NEUROD1 has similar functional and anatomic consequences in the human retina as those described in mice. The present description can help the diagnosis of future cases and provide clues on the rate of disease progression.


NEUROD1 is a tissue-specific basic helix loop helix (bHLH) transcription factor that plays an important role in the development and maintenance of neuronal elements [1] and the endocrine pancreas [2, 3]. It also plays a key role in maintaining normal glucose homeostasis [2, 3].

Most of our knowledge on the function of NEUROD1 comes from animal experiments. NEUROD1 is expressed in differentiated neurons of frogs and mice [4]. It has been shown that NEUROD1 can transform ectodermal cells into differentiated neurons in Xenopus [4]. In addition, NEUROD1 is expressed in the fully differentiated neurons of the adult Xenopus brain structures, including the hippocampus, cerebellum, and olfactory bulbs [4]. NEUROD1 null mutant mice kept alive by either a transgene encoding the mouse NEUROD1 gene under the insulin promoter [5] or by crossing the null mutation into a different genetic background [6] showed concordant neuronal phenotypes, including ataxic gate, impaired balance, circling, impaired cerebellar function [5-7], and epilepsy [6]. Abnormal hearing and vision are caused by sensory defects of the inner ear and neural retina [7-9].

Morrow et al. [9] investigated the expression of NEUROD1 in rat and mouse retinas. Despite the two different methods, NEUROD1 was found to be expressed mainly in undifferentiated retinal cells, developing amacrine interneurons, and photoreceptors. Moreover, its expression could be observed in terminally differentiated photoreceptors in the mature retina. The suppression of NEUROD1 gene expression leads to severe impairment of photoreceptor development in chick retinas, indicating its importance in the formation of photoreceptors [10].

To define the role of NEUROD1 in the retina, Ochocinska et al. [11] used NEUROD1 conditional knockout mice (cKO). They observed that two-month-old NEUROD1 cKO retinas underwent dramatic changes, including reductions in rod- and cone-driven electroretinograms and disorganized outer segments. Furthermore, photoreceptors totally disappeared in later ages. Microarray analysis identified two downregulated genes: Aipl1, which is necessary to prevent retinal degeneration, and Ankrd33, which is expressed in the outer segment of the retina. It is suggested that NEUROD1 is involved in receptor homeostasis through these genes [11]. Although NEUROD1 is expressed in all three layers of the mouse retina, degeneration only affects the photoreceptors [12]. In contrast, Acharya et al. [13] demonstrated that NEUROD1 transcripts and NEUROD1 immunoreactivity are predominantly localized to the outer nuclear layer in the adult human retina.

Heterozygous loss-of-function mutations in the NEUROD1 gene have been described in the background of maturity-onset diabetes of the young (MODY) and late-onset diabetes [14-17]. There are only two unrelated patients with two different homozygous loss-of-function NEUROD1 mutations described so far. Both single base pair duplication (c.364dupG) and two base pair CT deletion (c.427_428del) result in a frameshift and a premature truncation of the C-terminus of the expressed protein (p.Asp122Glyfs*12 and p.Leu143Alafs*55, respectively), leading to mutated proteins completely lacking the transactivation domain [18]. These two probands were diagnosed with permanent neonatal diabetes (PNDM) and had similar neurologic abnormalities, including cerebellar hypoplasia, developmental delay, and visual and hearing impairment [18]. Interestingly, the rescued NEUROD1-null mice [5-9] and the two NEUROD1-deficient patients showed similar disease manifestations except epilepsy, which was only seen in the mice [6]. However, no further information on the ophthalmic phenotype and its functional consequences was provided in that article.

In the present study, we provide detailed ophthalmological characterization of the patient with homozygous c.427_428delCT NEUROD1 mutation. To the best of our knowledge, this is the first description of the ophthalmological phenotype caused by a homozygous NEUROD1 null mutation.


Color fundus photographs were taken with a Zeiss FF450+IR fundus camera (Carl Zeiss AG, Jena, Germany) mounted with a ZK-5 color sensor (Allied Vision Technologies GmbH, Stadtroda, Germany) and operated with Zeiss Visupack 4.4 software. Optical coherence tomography and confocal-scanning laser fundus autofluorescence imaging were performed with SpectralisOCT (Heidelberg Engineering, Heidelberg, Germany). Electroretinography was executed with Ganzfeld Q400 equipment (Roland Consult GmbH, Brandenburg, Germany) using standard ISCEV parameters [19]. The visual field was investigated with an Octopus 900 automated static perimeter, using its standard white/white full-size visual field program (Haag Streit AG, Koenitz, Switzerland). All of the procedures applied in this study strictly adhered to the tenets of the Declaration of Helsinki.


We annually examined a female patient having neonatal diabetes caused by a homozygous loss-of-function mutation in the NEUROD1 gene between 2009 (age 14) and 2014 (age 19). The patient had normal blood glucose control using insulin supplementation. The patient complained about slowly progressive blurry vision, constriction of the visual field, and difficulties seeing at night or in dim light, beginning in early childhood. Her best corrected visual acuity showed a slow decrease during the exam period, ranging from 20/25 to 15/25. Refractive error did not show any changes between the examinations: -7.5D spherical with +3.0D cylindrical correction in both eyes. Automated full-size visual field perimetry showed concentric constriction of the visual field, sparing the central 30 degrees in both eyes, in 2013. The patient showed normal color recognition on pseudoisochromatic charts.

Scheimpflug imaging of the anterior segment showed regular oblique corneal astigmatism. Corneal thickness was near normal, with a central corneal thickness of 600 µm. No signs of Keratoconus could be detected with Scheimpflug imaging using the Belin-Ambrosio analysis. Anterior chamber depth and anterior chamber angle were within the normal range. Dilated funduscopy revealed optically clear media throughout the cornea, lens, and vitreous. The retinal pigmented epithelial layer showed mottling at the posterior pole and diffuse atrophy in the periphery (Figure 1). However, neither bone spicule formation nor pigment clumping could be observed. Unlike the pale and waxy optic disc associated with retinitis pigmentosa (RP), the optic disc in her case was slightly pale but had a near normal appearance. The diameter of retinal vessels was apparently normal, and vascular attenuation could not be observed. The central foveal spot was enlarged (Figure 1). Diabetic retinopathy was not observed during the investigation period.

Fundus autofluorescence imaging presented a dark fovea surrounded by a hyperreflective ring, as seen in other hereditary retinal dystrophies [20]. Increased autofluorescence of the choroid was detected, most likely due to the atrophy and mottling of the RPE in the posterior pole. No typical spot or patchy reflectance of lipofuscin could be seen. Optical coherence tomography showed reduced retinal thickness. Outside the fovea, the neurosensory retina was composed of only six layers, lacking the external limiting membrane, photoreceptor outer segment, and photoreceptor inner segment. An optically dense discoid remnant of photoreceptors was detected in the central fovea. The extent of the disc representing photoreceptors in the fovea showed constriction during the investigation period, indicating the progressive loss of cone photoreceptors (Figure 2).

Electric signals of retinal origin could not be differentiated from background noise with any of the standard ERG settings, including the dark-adapted 0.01 ERG (rod response), dark-adapted 3.0 ERG (maximal combined rod-cone response), dark-adapted 3.0 oscillatory potentials, light-adapted 3.0 ERG (single-flash photopic ERG), and light-adapted 3.0 flicker ERG (30 Hz flicker) settings (Figure 3). Peripapillary nerve–fiber layer thickness showed normal values in both eyes.


NEUROD1 takes part in the development of the endocrine pancreas and neuronal elements, including the retina. Most of our knowledge about the function of the protein comes from animal experiments. NEUROD1 knockout animals die shortly after birth due to severe diabetes. Long-term effects of gene knockout on the retina could only be investigated either by prolonging survival [6, 8] or restricting the gene knockout to the retina [11]. Pennesi et al. [8] investigated the role of NEUROD1 in the retina using knockout mice that survived until adulthood. The two- to three-month-old homozygous null mice showed a reduction in rod- and cone-driven electroretinograms and shortened outer photoreceptor segments. The thicknesses of the outer nuclear and the outer plexiform layers were reduced, but there were no changes in the inner nuclear, inner plexiform, and ganglion cell layers. In addition, the 18-month-old NEUROD1 KO retina was totally devoid of photoreceptors. Ochocinska et al. [11] used conditional KO mice to investigate the role of NEUROD1 in the adult retina. The retinal morphology represented a shortened and disorganized outer segment and dramatic reduction in rod- and cone-driven electroretinograms at two months of age. At older ages, photoreceptors were completely absent. Photoreceptor damage equally affected rods and cones. However, for the inner nuclear, inner plexiform, and ganglion cell layers, no obvious morphological changes were seen. These findings suggest that NEUROD1 plays an important role in maintaining functional and structural integrity of the photoreceptors, and that homozygous null mice progress rapidly to the complete loss of photoreceptors.

Homozygous null mutations in the NEUROD1 gene were suspected to be lethal in humans [8] until Cabezas et al. [18] reported two patients with homozygous loss-of-function mutations in the NEUROD1 gene in 2010. Both patients had permanent neonatal diabetes and severe neurologic abnormalities, including cerebellar hypoplasia, developmental delay, and visual and hearing impairment. However, detailed ophthalmological phenotypes of patients with homozygous NEUROD1 null mutations have not yet been documented. Our purpose with the present study was therefore to provide a detailed description of the functional and anatomic characteristics attributed to a homozygous NEUROD1 null mutation in humans and to compare our findings with those described in animal models.

The young female patient reported by Cabezas [18] with the homozygous c.427_428delCT NEUROD1 mutation was investigated on multiple occasions in a five-year period. The patient had diminished night vision from early childhood and showed severe visual field constriction with mostly preserved central visual acuity. These symptoms are similar to those caused by typical retinitis pigmentosa and indicate a rod–cone dystrophy pattern. In line with these symptoms, optical coherence tomography showed a discoid remnant of cone photoreceptors in the fovea and a total lack of photoreceptors outside the fovea. In this region, the retina was totally devoid of photoreceptors. Electroretinography showed absent dark- and light-adapted responses. The lack of dark-adapted ERG responses can be explained by the total lack of rod photoreceptors. Undetectable cone responses in the light-adapted ERG settings can be explained by the reduction in the number of cone photoreceptors and a damaged photoreceptor function. Despite the severely diminished retinal function, the ocular fundus was less compromised than with typical retinitis pigmentosa. Although RPE showed mottling in the posterior pole, no bone spicules or pigment clumps were present. Optic-disc pallor and retinal-vessel attenuation were also less prominent than in RP cases. Fundus autofluorescence imaging showed increased fundus autofluorescence and a hyperreflective parafoveal ring. This phenomenon has been described in cases of retinitis pigmentosa [20-23], rod–cone dystrophies [24], and other inherited retinal diseases [24-26]. Our result is in accordance with the presumption that the ring can be a prognostic factor of macular dysfunction [20, 22, 27, 28] and corresponds to a transition zone between a functional and dysfunctional retina [20, 27-29].

Most of our knowledge on the function of NEUROD1 comes from animal models. NEUROD1 seems to be necessary for the maintenance of normal photoreceptor structure and function. The absence of NEUROD1 leads to severe retinal dystrophy [8, 13]. Our study demonstrates the first detailed description of an ophthalmological phenotype caused by a homozygous NEUROD1 null mutation in humans and indicates that it causes severe rod–cone dystrophy. Although it resembles retinitis pigmentosa in many aspects, it can be clearly distinguished from it. The relatively spared pigmented epithelial layer, the normal appearance of the optic disc and retinal vessel, and the disc-shaped remnant of cone photoreceptors in the fovea are characteristic hallmarks of the disease, distinguishing it from any other hereditary retinal dystrophies. The total lack of rod photoreceptors, sharply demarcated from relatively spared foveal photoreceptors, is also an unusual phenotype.

Therefore, we believe that this case not only represents a novel genotype–phenotype correlation but also delineates a novel form of syndromatous hereditary retinal dystrophy, and provides insight into the role of NEUROD1 in retinal homeostasis. Moreover, we cannot exclude the possible role of the NEUROD1 gene in non-syndromatous retinal dystrophies of so-far undetermined genetic origin. The findings of our report confirm the observations of knockout animal models. To the best of our knowledge, this is the first detailed description of the ophthalmological consequences of a homozygous NEUROD1 mutation in humans. Our results are the first to show that the loss of NEUROD1 has similar effects on the human retina as have been previously shown in animal experiments. Our report can help in diagnosing NEUROD1-related retinal dystrophies in the future and provides information on disease progression.


This study was supported by the Hungarian Research Fund OTKA K109076.


  1. Lee JK, Cho JH, Hwang WS, Lee YD, Reu DS, Suh-Kim H. Expression of NeuroD/BETA2 in mitotic and postmitotic neuronal cells during the development of nervous system. Dev Dyn. 2000; 217:361-7. [PMID: 10767080]
  2. Naya FJ, Huang HP, Qiu Y, Mutoh H, DeMayo FJ, Leiter AB, Tsai MJ. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/ NeuroD-deficient mice. Genes Dev. 1997; 11:2323-34. [PMID: 9308961]
  3. Bernardo AS, Hay CW, Docherty K. Pancreatic transcription factors and their role in the birth, life and survival of the pancreatic beta cell. Mol Cell Endocrinol. 2008; 294:1-9. [PMID: 18687378]
  4. Lee JE, Hollenberg SM, Snider L, Turner DL, Lipnick N, Weintraub H. Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. Science. 1995; 268:836-44. [PMID: 7754368]
  5. Miyata T, Maeda T, Lee JE. NeuroD is required for differentiation of the granule cells in the cerebellum and hippocampus. Genes Dev. 1999; 13:1647-52. [PMID: 10398678]
  6. Liu M, Pleasure SJ, Collins AE, Jeffrey L, Noebels JL, Naya FJ, Tsai MJ, Lowenstein DH. Loss of BETA2/ NeuroD leads to malformation of the dentate gyrus and epilepsy. Proc Natl Acad Sci USA. 2000; 97:865-70. [PMID: 10639171]
  7. Liu M, Pereira FA, Price SD, Chu MJ, Shope C, Himes D, Eatock RA, Brownell WE, Lysakowski A, Tsai MJ. Essential role of BETA2/NeuroD1 in development of the vestibular and auditory systems. Genes Dev. 2000; 14:2839-54. [PMID: 11090132]
  8. Pennesi ME, Cho JH, Yang Z, Wu SH, Zhang J, Wu SM, Tsai MJ. BETA2/NeuroD1 null mice: A new model for transcription factor-dependent photoreceptor degeneration. J Neurosci. 2003; 23:453-61. [PMID: 12533605]
  9. Morrow EM, Furukawa T, Lee JE, Cepko CL. NeuroD regulates multiple functions in the developing neural retina in rodent. Development. 1999; 126:23-6. [PMID: 9834183]
  10. Yan RT, Wang SZ. Requirement of NeuroD for Photoreceptor Formation in the Chick Retina. Invest Ophthalmol Vis Sci. 2004; 45:48-58. [PMID: 14691153]
  11. Ochocinska MJ, Munoz EM, Veleri S, Weller JL, Coon SL, Pozdeyev N, Iuvone PM, Goebbels S, Furukawa T, Klein DC. NeuroD1 is required for survival of photoreceptors but not pinealocytes: Results from targeted gene deletion studies. J Neurochem. 2012; 123:44-59. [PMID: 22784109]
  12. Cho JH, Klein WH, Tsai MJ. Compensational regulation of bHLH transcription factors in the postnatal development of BETA2/NeuroD1-null retina. Mech Dev. 2007; 124:543-50. [PMID: 17629466]
  13. Acharya HR, Dooley CM, Thoreson WB, Ahmad I. cDNA cloning and expression analysis of NeuroD in Human Retina. Biochem Biophys Res Commun. 1997; 233:459-63. [PMID: 9144558]
  14. Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, Saad M, Warram JH, Montminy M, Krolewski AS. Mutations in NEUROD1 are associated with the development of type-2 diabetes mellitus. Nat Genet. 1999; 23:323-8. [PMID: 10545951]
  15. Gonsorcíková L, Pruhová S, Cinek O, Ek J, Pelikánová T, Jorgensen T, Eiberg H, Pedersen O, Hansen T, Lebl J. Autosomal inheritance of diabetes in two families characterized by obesity and a novel H241Q mutation in NEUROD1. Pediatr Diabetes. 2008; 9:367-72. [PMID: 18331410]
  16. Liu L, Furuta H, Minami A, Zheng T, Jia W, Nanjo K, Xiang K. A novel mutation, Ser159Pro in the NeuroD1/BETA2 gene contributes to the development of diabetes in a Chinese potential MODY family. Mol Cell Biochem. 2007; 303:115-20. [PMID: 17440689]
  17. Kristinsson SY, Thorolfsdottir ET, Talseth B, Steingrimsson E, Thorsson AV, Helgason T, Hreidarsson AB, Arngrimsson R. MODY in Iceland is associated with mutations in HNF-1alpha and a novel mutation in NeuroD1. Diabetologia. 2001; 44:2098-03. [PMID: 11719843]
  18. Rubio-Cabezas OR, Minton JAL, Kantor I, Williams D, Ellard S, Hattersley AT. Homozygous mutations in NEUROD1 are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities. Diabetes. 2010; 59:2326-31. [PMID: 20573748]
  19. Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol. 2009; 118:69-77. [PMID: 19030905]
  20. Fleckenstein M, Charbel Issa P, Fuchs HA, Finger RP, Helb HM, Scholl HPN, Holz FG. Discrete arcs of increased fundus autofluorescence in retinal dystrophies and functional correlate on microperimetry. Eye (Lond). 2009; 23:567-75. [PMID: 18344954]
  21. Murakami T, Akimoto M, Ooto S, Suzuki T, Ikeda H, Kawagoe N, Takahashi M, Yoshimura N. Association between abnormal autofluorescence and photoreceptor disorganization in retinitis pigmentosa. Am J Ophthalmol. 2008; 145:687-94. [PMID: 18242574]
  22. Lima LH, Cella W, Greenstein VC, Wang N, Busuioc M, Smith RT, Yannuzzi LA, Tsang SH. Structural assessment of hyperautofluorescent ring in patients with retinitis pigmentosa. Retina. 2009; 29:1025-31. [PMID: 19584660]
  23. Robson AG, El-Amir A, Bailey C, Egan CA, Fitzke FW, Webster AR, Bird AC, Holder GE. Pattern ERG correlates of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Invest Ophthalmol Vis Sci. 2003; 44:3544-50. [PMID: 12882805]
  24. Wabbels B, Demmler A, Paunescu K, Wegscheider E, Preising MN, Lorenz B. Fundus autofluorescence in children and teenagers with hereditary retinal diseases. Graefes Arch Clin Exp Ophthalmol. 2006; 244:36-45. [PMID: 16034607]
  25. Robson AG, Michaelides M, Luong VA, Holder GE, Bird AC, Webster AR, Moore AT, Fitzke FW. Functional correlates of fundus autofluorescence abnormalities in patients with RPGR or RIMS1 mutations causing cone or cone-rod dystrophy. Br J Ophthalmol. 2008; 92:95-102. [PMID: 17962389]
  26. Robson AG, Michaelides M, Saihan Z, Bird AC, Webster AR, Moore AT, Fitzke FW, Holder GE. Functional characteristics of patients with retinal dystrophy that manifest abnormal parafoveal annuli of high density fundus autofluorescence, a review and update. Doc Ophthalmol. 2008; 116:79-89. [PMID: 17985165]
  27. Lenassi E, Troeger E, Wilke R, Hawlina M. Correlation between macular morphology and sensitivity in patients with retinitis pigmentosa and hyperautofluorescent ring. Invest Ophthalmol Vis Sci. 2012; 53:47-52. [PMID: 22110079]
  28. Popovíc P, Jarc-Vidmar M, Hawlina M. Abnormal fundus autofluorescence in relation to retinal function in patients with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol. 2005; 243:1018-27. [PMID: 15906064]
  29. Aizawa S, Mitamura Y, Hagiwara A, Sugawara T, Yamamoto S. Changes of fundus autofluorescence, photoreceptor inner and outer segment junction line, and visual function in patients with retinitis pigmentosa. Clin Experiment Ophthalmol. 2010; 38:597-604. [PMID: 20456441]